22 results
6-K
EX-1.1
IPHA
Innate Pharma
6 Feb 24
Current report (foreign)
5:05pm
by the Commission and the U.S. Public Company Accounting Oversight Board. Deloitte & Associés is an independent statutory auditor with
respect to the Company
6-K
EX-1.1
IPHA
Innate Pharma
26 Apr 23
Current report (foreign)
4:02pm
by the Commission and the U.S. Public Company Accounting Oversight Board. Deloitte & Associés is an independent statutory auditor with respect to the Company
6-K
EX-1.1
j3dk2tp
3 May 22
Current report (foreign)
5:08pm
20-F
ygcpi
24 Apr 20
Annual report (foreign)
10:43am
424B4
cmc bzcd1srktt2
18 Oct 19
Prospectus supplement with pricing info
4:08pm
F-1/A
EX-1.1
gwz0z
4 Oct 19
Registration statement (foreign) (amended)
4:56pm
F-1/A
paj9vbphsc ab3if
4 Oct 19
Registration statement (foreign) (amended)
4:56pm
F-1
EX-10.2
03zx54exdpa9x
20 Sep 19
Registration statement (foreign)
4:08pm
F-1
s1dmk
20 Sep 19
Registration statement (foreign)
4:08pm
F-1
EX-10.5
16gdyb
20 Sep 19
Registration statement (foreign)
4:08pm
F-1
EX-10.3
or30xgpf7c73mji9xca
20 Sep 19
Registration statement (foreign)
4:08pm
DRS/A
EX-10.2
lffhthlb wv
30 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
EX-10.3
jr1dn1tmvciiq
30 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
priehyoo3l04364kbl
30 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
jt2fn1kp4bgzv4kj24f
19 Jul 19
Draft registration statement (amended)
12:00am